These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 19091653)
1. [Ductal adenocarcinoma of the head of the pancreas: a critical study of R1 resection rates]. Delpero JR; Turrini O Bull Cancer; 2008 Dec; 95(12):1193-8. PubMed ID: 19091653 [TBL] [Abstract][Full Text] [Related]
2. Resection margins and R1 rates in pancreatic cancer--are we there yet? Verbeke CS Histopathology; 2008 Jun; 52(7):787-96. PubMed ID: 18081813 [TBL] [Abstract][Full Text] [Related]
3. Most pancreatic cancer resections are R1 resections. Esposito I; Kleeff J; Bergmann F; Reiser C; Herpel E; Friess H; Schirmacher P; Büchler MW Ann Surg Oncol; 2008 Jun; 15(6):1651-60. PubMed ID: 18351300 [TBL] [Abstract][Full Text] [Related]
4. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection]. Ridwelski K; Meyer F; Schmidt U; Lippert H Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961 [TBL] [Abstract][Full Text] [Related]
5. R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use. Rau BM; Moritz K; Schuschan S; Alsfasser G; Prall F; Klar E Surgery; 2012 Sep; 152(3 Suppl 1):S103-11. PubMed ID: 22766366 [TBL] [Abstract][Full Text] [Related]
6. Long-term survival (5-20 years) after pancreatectomy for pancreatic ductal adenocarcinoma: a series of 30 patients collected from 3 institutions. Adham M; Jaeck D; Le Borgne J; Oussoultzouglou E; Chenard-Neu MP; Mosnier JF; Scoazec JY; Mornex F; Partensky C Pancreas; 2008 Nov; 37(4):352-7. PubMed ID: 18665012 [TBL] [Abstract][Full Text] [Related]
7. Postoperative cytology for drained fluid from the pancreatic bed after "curative" resection of pancreatic cancers: does it predict both the patient's prognosis and the site of cancer recurrence? Ishikawa O; Wada H; Ohigashi H; Doki Y; Yokoyama S; Noura S; Yamada T; Sasaki Y; Imaoka S; Kasugai T; Matsunaga T; Takenaka A; Nakaizumi A Ann Surg; 2003 Jul; 238(1):103-10. PubMed ID: 12832972 [TBL] [Abstract][Full Text] [Related]
8. Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trials. Butturini G; Stocken DD; Wente MN; Jeekel H; Klinkenbijl JH; Bakkevold KE; Takada T; Amano H; Dervenis C; Bassi C; Büchler MW; Neoptolemos JP; Arch Surg; 2008 Jan; 143(1):75-83; discussion 83. PubMed ID: 18209156 [TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of Resection Margin Involvement After Pancreaticoduodenectomy for Ductal Adenocarcinoma: Updates From a French Prospective Multicenter Study. Delpero JR; Jeune F; Bachellier P; Regenet N; Le Treut YP; Paye F; Carrere N; Sauvanet A; Adham M; Autret A; Poizat F; Turrini O; Boher JM Ann Surg; 2017 Nov; 266(5):787-796. PubMed ID: 28953554 [TBL] [Abstract][Full Text] [Related]
13. Different approaches to assessment of lymph nodes and surgical margin status in patients with ductal adenocarcinoma of the pancreas treated with pancreaticoduodenectomy. Liszka Ł; Pajak J; Zielińska-Pajak E; Gołka D; Mrowiec S; Lampe P Pathology; 2010 Feb; 42(2):138-46. PubMed ID: 20085515 [TBL] [Abstract][Full Text] [Related]
14. Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection? Konstantinidis IT; Warshaw AL; Allen JN; Blaszkowsky LS; Castillo CF; Deshpande V; Hong TS; Kwak EL; Lauwers GY; Ryan DP; Wargo JA; Lillemoe KD; Ferrone CR Ann Surg; 2013 Apr; 257(4):731-6. PubMed ID: 22968073 [TBL] [Abstract][Full Text] [Related]
20. Survival after pancreaticoduodenectomy is not improved by extending resections to achieve negative margins. Hernandez J; Mullinax J; Clark W; Toomey P; Villadolid D; Morton C; Ross S; Rosemurgy A Ann Surg; 2009 Jul; 250(1):76-80. PubMed ID: 19561479 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]